APA (7th ed.) Citation

Y, Z., LT, N., LJ, H., & M, L. (2022). Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification. Frontiers in oncology, 12, 947492. https://doi.org/10.3389/fonc.2022.947492

Chicago Style (17th ed.) Citation

Y, Zhao, Niu LT, Hu LJ, and Lv M. "Comprehensive Analysis of ECHDC3 as a Potential Biomarker and Therapeutic Target for Acute Myeloid Leukemia: Bioinformatic Analysis and Experimental Verification." Frontiers in Oncology 12 (2022): 947492. https://doi.org/10.3389/fonc.2022.947492.

MLA (9th ed.) Citation

Y, Zhao, et al. "Comprehensive Analysis of ECHDC3 as a Potential Biomarker and Therapeutic Target for Acute Myeloid Leukemia: Bioinformatic Analysis and Experimental Verification." Frontiers in Oncology, vol. 12, 2022, p. 947492, https://doi.org/10.3389/fonc.2022.947492.